Dinkelborg, Patrick H.
Wang, Meng
Gheorghiu, Liliana
Gurski, Joseph M.
Hong, Theodore S.
Benes, Cyril H.
Juric, Dejan
Jimenez, Rachel B.
Borgmann, Kerstin
Willers, Henning http://orcid.org/0000-0002-3938-5732
Funding for this research was provided by:
American Cancer Society (123420RSG-12-224-01-DMC)
Wellcome Trust (102696)
WERNER-OTTO-STIFTUNG HAMBURG (N/A)
National Cancer Institute (U01CA220714)
Article History
Received: 16 March 2018
Accepted: 29 November 2018
First Online: 3 January 2019
Compliance with ethical standards
:
: The following authors declare: Benes, C.H.—funding from Novartis, Amgen, Araxes; Hong, T. S.—consultant/advisory role: Clinical Genomics, EMD Serono, funding from Novartis, Taiho; Juric, D.—consultant/advisory role: Novartis, EMD Serono, Eisai, Genentech. All other authors declare that they have no conflict of interest.
: All patient tumor samples were collected under a protocol approved by the institutional review board.